Different pathological studies have shown that the manner in which α-syn is topographically spread (transitional vs. diffuse Lewy body disease) and other synergistic actions (Aβ and tau co-pathology) may influence the clinical presentation and therefore the diagnosis received early in the disease process. The gene discussed is MAPT; the disease is Lewy body dementia.